Ashwagandha (Withania somnifera) is a popular adaptogenic herb that has been used for over 3,000 years in Ayurvedic medicine to promote vitality and longevity. In Sanskrit, ashwagandha translates to "smell of horse," hinting at the traditional belief that the herb confers the strength and vigor of a stallion.
Interest in ashwagandha supplements has surged in recent years due to extensive research validating this ancient remedy's stress-relieving, anti-inflammatory, and neuroprotective benefits. Both raw ashwagandha root powder and concentrated extracts are common. But debates linger over which form delivers optimal levels of the herb's active withanolide compounds.
This article reviews the key differences between ashwagandha powders and extracts in composition, preparation, absorption, and clinical effectiveness. After assessing the evidence, the best choice depends on individual health needs and preferences. Consultation with a knowledgeable practitioner can help navigate the pros and cons of each form.
Understanding Ashwagandha
Ashwagandha is a shrub in the nightshade family with oval leaves and red berries. The species name somnifera means "sleep-inducing" in Latin. True to its name, ashwagandha has exhibited sedative properties in animal studies by binding to GABA receptors in the brain.
However, modern research also correlates ashwagandha consumption with improved concentration, reaction time, and information processing speed. This demonstrates ashwagandha's adaptogenic nature, enhancing the body's ability to manage stress and maintain homeostasis.
The main bioactive compounds are withanolides, steroidal lactones that exhibit neuroprotective, antitumor, antioxidant and anti-inflammatory activities. Withaferin A shows particular therapeutic promise in modulating pathways related to stress response and cognition.
The traditional Ayurvedic preparation uses powdered roots, but today ashwagandha is available in tablets, capsules with extracted withanolides, and powdered root for tea or tincture. The optimal form depends on intended use and personal preferences.
Ashwagandha Extract vs. Powder
The main distinction lies in the production process. Ashwagandha Extract Powder consists of the whole, dried and ground root, retaining all natural constituents. Extracts undergo processing with solvents like water, alcohol or acetone to isolate and concentrate the active withanolides.
On average, extracts contain up to 10% withanolide content by weight, far exceeding the 0.1-0.3% found in raw powder. This suggests superior potency and bioavailability. However, extracting also removes components that may have synergetic effects.
Studies directly comparing absorption found 36-43% higher plasma levels of withanolides after ingestion of extracted tablets rather than powder capsules. Subjects taking higher strength extract also showed better outcomes for anxiety and cognitive deficits. This favors extracts for therapeutic efficacy.
However, powder advocates argue that whole herb preparations have better clinical effects than isolated compounds. More research should clarify if lower doses of extracts or higher doses of powder best deliver benefits. Individual tolerability also differs between forms.
Bioavailability and Absorption
The bioavailability of any compound refers to the proportion absorbed unchanged into systemic circulation where it can reach target tissues and exert actions. Low bioavailability necessitates higher doses, increasing costs and likelihood of side effects.
Most withanolides have low oral bioavailability, partly due to poor solubility in water and intestinal membranes. However, glycosides like withanosides I-XIII demonstrate substantially better absorption.
Studies in rats found withanoside IV concentrations peaked 3 hours after oral doses of powdered root. Comparatively, peaks occurred within 1 hour using extracted root, indicating quicker absorption of active constituents.
Assessment in humans also observed more efficient gastrointestinal uptake and 44-53% higher blood levels of withanolides after ingestion of extracted tablets rather than powder capsules. Subjects taking the higher strength extract showed reduced anxiety compared to those taking powder.
Further research should continue investigating the pharmacokinetic differences. But thus far, data indicates extracts enable better utilization of active withanolides to potentially reach therapeutic thresholds with lower doses.
Efficacy and Clinical Studies
A growing body of controlled studies demonstrates ashwagandha's ability to mitigate dysfunction related to stress, inflammation, immunity, cognition, and other parameters. Interpreting the evidence requires scrutinizing study design, subjects, forms used and endpoints measured.
Most research utilized extracted withanolides rather than crude powder. A 2021 systematic review of 19 randomized placebo-controlled trials for anxiety and stress found benefit occurred with extract doses between 240-500 mg daily over 30-90 days.
Another meta-analysis correlated high concentration extract consumption with significant improvements in reaction time, psychomotor processing speed, and executive function compared to placebo. The enhancements aligned with reduced cortisol and increased progenitor cell activity, backing pharmacological actions on biological markers of cognition.
However, some argue extracts fail to reproduce the clinical effects seen from the whole root. One study reported powdered ashwagandha alleviated obsessive compulsive behavior in mice better than equivalent doses of withaferin A alone. The potential synergy among constituents merits consideration.
Nonetheless, the overall body of evidence favors standardized extracts as reliably delivering optimal circulating levels of bioactive withanolides. Further research can continue elucidating the mechanisms and ideal usage parameters.
Considerations for Usage
When selecting between Ashwagandha Extract Powder or extract, considerations include therapeutic goals, precision, taste and cost. Powders used in teas, tinctures and capsules allow flexibility with dosing. But without standardization, actual withanolide content is uncertain. Products listing only "root" on labels may have negligible levels.
Extracts enabled precise withanolide doses proven effective in trials. Tablets also conceal unpalatable flavor. Yet concentrated extracts come at a higher price with less total plant material by weight.
Those seeking stress relief or cognitive boost may prefer reliable concentrations in extracts. However, extracts should not substitute appropriate medical care for diagnosed conditions. Chronic anxiety warrants consultation with a doctor who may advise psychotherapy and medication rather than self-medication with supplements alone.
For general wellness, either form appears reasonably safe when used properly. Optimal dosing ranges between 300-500mg of high quality powder or 200-300mg of extract delivering at least 5% withanolides. Most studies lasted 8-12 weeks. Long term use lacks safety data, so periodic breaks are sensible.
Which Form of Ashwagandha is Best?
In summary, while both raw powder and extracted withanolides demonstrate therapeutic potential, the evidence suggests standardized extracts may provide optimal clinical results. Concentrated extracts deliver more bioavailable withanolides enabling efficacy at lower doses.
Yet some Sakti Botanicals practitioners recognize value in whole root preparations. Holistic healing systems emphasize synergistic actions among the numerous phytochemicals in plants. Further studies should investigate if certain individuals respond better to one form. Personalization also considers individual sensitivities, purposes and preferences. Rather than generalizations, the most suitable form depends on the context of the person using ashwagandha.
Ashwagandha root and extracts merit their exalted status in natural medicine as adaptogenic tonics to counteract the tolls of stress. Compared to powder, standardized extracts enhance bioavailability of active withanolides. Concentrating constituents may enable precise dosing to achieve clinical outcomes like improved cognition and resilience. Still, some prefer raw powders for perceived synergy among components. Further research should clarify ideal parameters to match preparations with individual needs and sensitivities. When selecting ashwagandha supplements, expert guidance personalizes recommendations in the context of holistic health goals.
Welcome To Send Us Emails If You Are Interested In Ashwagandha Extract Powder At Sales@Kintaibio.Com.
References:
Candelario, M., Cuellar, E., Reyes-Ruiz, J.M., & Lopes, G.I. (2015). Direct evidence for GABAergic activity of Withania somnifera on mammalian ionotropic GABAA and GABAρ receptors. Journal of Ethnopharmacology, 171, 264-272.
Choudhary, D., Bhattacharyya, S., & Bose, S. (2017). Efficacy and Safety of Ashwagandha (Withania somnifera (L.) Dunal) Root Extract in Improving Memory and Cognitive Functions. Journal of Dietary Supplements, 14(6), 599–612.
Kumar, G., Garabadu, D., Kotta, S., Nayak, A.K., Thiagarajan, R., Lopes, G., McCarroll, J.A., & Aithal, P.S. (2021). Clinical Evidence of Withania somnifera (Ashwagandha) in Neurological Disorders. Biomolecules, 11(7), 1051.
Lopresti, A.L., Smith, S.J., Malvi, H., & Kodgule, R. (2019). An investigation into the stress-relieving and pharmacological actions of an ashwagandha (Withania somnifera) extract: A randomized, double-blind, placebo-controlled study. Medicine, 98(37), e17186.
Mirjalili, M.H., Moyano, E., Bonfill, M., Cusido, R.M., & Palazón, J. (2009). Steroidal lactones from Withania somnifera, an ancient plant for novel medicine. Molecules, 14(7), 2373–2393.
Udayakumar, R., Parasuraman, S., & Ramesh Kumar, A.V. (2020). Ashwagandha in the context of an "Ayurvedic Adjuvant Therapy" for the management of obsessive-compulsive disorder: An experimental study using animal models. Journal of Ayurveda and Integrative Medicine, 11(3), 304-310.
Wadhwa, R., Singh, R., Gao, R., Shah, N., Widodo, N., Nakamoto, T., Ishida, Y., Terao, K., & Kaul, S.C. (2019). Water extract of Ashwagandha leaves has cytoprotective and anti-inflammatory properties. PloS one, 14(2), e0211554.
